Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Juan F. Iglesias,Dik Heg,Marco Roffi,David Tüller,Stéphane Noble,Olivier Muller,Igal Moarof,Stéphane Cook,Daniel Weilenmann,Christoph Kaiser,Florim Cuculi,Jonas Dominik Häner,Peter Jüni,Stephan Windecker,Thomas Pilgrim

Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

2019

Juan F. Iglesias
Dik Heg
Marco Roffi
David Tüller
Stéphane Noble
Olivier Muller
Igal Moarof
Stéphane Cook
Daniel Weilenmann
Christoph Kaiser
Florim Cuculi
Jonas Dominik Häner
Peter Jüni
Stephan Windecker
Thomas Pilgrim

Background: Randomized trials evaluating the Orsiro biodegradable polymer sirolimus-eluting stent (BP-SES; 60 and 80 μm strut thickness for stent diameters ≤3 and >3 mm, respectively) did not strat...

Keywords:

Stent
Sirolimus
Drug-eluting stent
Internal medicine
Percutaneous coronary intervention
Coronary artery disease
Drug
Medicine
Randomized controlled trial
Everolimus
Cardiology
Subgroup analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations